Bharti Ranavaya

Board Observer @H.A.L.O Inc.

Toronto, CA
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Apr 2025 — Present

Board Observer @H.A.L.O Inc.

View department →

Toronto, ON, CA

EDUCATION

2002 — 2007

University of Birmingham

PhD

2022

University of Toronto - Rotman School of Management

Advanced Negotiations Program

2018 — 2019

York University

Intellectual Property Licensing Certification

2025 — 2025

University of Toronto - Rotman School of Management

Organizational Leadership

2025 — 2025

University of Toronto - Rotman School of Management

Executive Presence

1998 — 2002

University of the West of England

BSc Honours (2.1)

SKILLS

Pharmaceutical IndustryLife SciencesMolecular BiologyPatentsDrug DiscoveryR&DVenture CapitalTechnology EvaluationIntellectual PropertyBiotechnologyChemistryResearch and Development (R&D)Innovation ManagementBiochemistryLicensingCommercializationManagementProduct DevelopmentTechnology TransferHealthcareBusiness DevelopmentMarket ResearchIntellectual Property ValuationImmunologyLifesciencesBusiness PlanningOpen InnovationProject ManagementMedical DevicesBusiness StrategyStart-UpsGenomicsNew Business DevelopmentStrategyEntrepreneurship

ABOUT BHARTI RANAVAYA

Bharti builds and scales ventures at the intersection of hospital innovation, deep science and capital, as a board‑level venture creation leader and bi‑jurisdictional UK–Canada commercialization expert. She has translated university & hospital IP into spin‑outs and licenses across therapeutics, MedTech, diagnostics and digital health.​As Head of Ventures at UHN, she is architecting an institutional venture engine that systematically surfaces, de‑risks and spins out high‑value clinical and research innovations, whilst assembling founding and management teams around them. She also serve on boards and as a board observer for emerging life sciences and digital health companies, bringing end‑to‑end experience from IP and FTO strategy through transaction design, capital formation and post‑deal value creation.​Previously, she designed and implement Canada’s first hospital proof‑of‑concept fund in oncology and drove commercialization strategies at Oxford University Innovation and NHS Innovations London, providing her with a rare combination of institutional fund architect, spin‑out builder and commercialization operator, across two major health innovation ecosystems.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Bharti Ranavaya — Board Observer at H.A.L.O Inc. in Toronto, CA | Unifers